Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.

por Horber, D. H., Schott, H., Schwendener, R. A.
Publicado 1995

Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N(4)-octadecyl-1-β-D-arabinofuranosylcytosine in Daudi lymphoma cells

por Koller-Lucae, S K M, Schott, H, Schwendener, R A
Publicado 1999

Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine.

por Horber, D. H., von Ballmoos, P., Schott, H., Schwendener, R. A.
Publicado 1995

Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice.

por Rentsch, K. M., Horber, D. H., Schwendener, R. A., Wunderli-Allenspach, H., Hänseler, E.
Publicado 1997

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

por Marty, C, Odermatt, B, Schott, H, Neri, D, Ballmer-Hofer, K, Klemenz, R, Schwendener, R A
Publicado 2002

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

por Zeisberger, S M, Odermatt, B, Marty, C, Zehnder-Fjällman, A H M, Ballmer-Hofer, K, Schwendener, R A
Publicado 2006